Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study.
Koch E, Kämpe A, Alver M, Sigurðarson S, Einarsson G, Partanen J, Smith RL, Jaholkowski P, Taipale H, Lähteenvuo M, Steen NE, Smeland OB, Djurovic S, Molden E; FinnGen; Estonian Biobank Research Team; Sigurdsson E, Stefánsson H, Stefánsson K, Palotie A, Milani L, O'Connell KS, Andreassen OA.
Koch E, et al. Among authors: smith rl.
Neuropsychopharmacology. 2024 Jun;49(7):1113-1119. doi: 10.1038/s41386-023-01792-0. Epub 2024 Jan 6.
Neuropsychopharmacology. 2024.
PMID: 38184734